Cantor Fitzgerald Upgrades Vanda Pharmaceuticals (VNDA) to Overweight
Tweet Send to a Friend
Cantor Fitzgerald analyst Charles Duncan upgraded Vanda Pharmaceuticals (NASDAQ: VNDA) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
